GEO,CXW Analysis: GEO Q4 2025: Record Execution at 48% Performance Gap to CoreCivic

The Setup

GEO Group reported its strongest growth quarter in company history — $520M in new annualized contracts (transcript line 17), record ICE populations at 24,000 (all-time high, line 23), and 13-18% revenue growth guidance for 2026 (line 92). The stock closed at $14.21 on Feb 14, 2026, down 47.9% over the past year at RSI 28, sitting at 7% of its 52-week range.

CoreCivic (CXW), with identical policy tailwinds and client base, is up 0.5% over the same period at $18.92, RSI 54.

Performance divergence: 48.4 percentage points.

Valuation gap: GEO trades at 7.8x P/E vs CXW's 17.5x — a 55% discount.

Analyst consensus on GEO: $27-50 price targets (90-250% upside), all "Strong Buy" or "Buy" ratings (MarketBeat, TipRanks).

Same business model. Same funding (OBBBA $75B through Sept 2029). But the market treats these two companies as if they operate in different industries.

What the Earnings Call Confirmed

Record Contract Wins

GEO won $520M in annualized new business in 2025 — the largest year in company history (line 17). Activated 5 facilities (≈6,000 beds, $400M annualized revenue, line 22) and hired 2,000 employees. ICE population in GEO facilities rose from ≈22,000 in Q3 to 24,000 in February 2026 — all-time highs (line 23).

2026 guidance: Revenue $2.9-3.1B (13-18% growth), adjusted EBITDA $490-510M, EPS $0.99-1.07 vs $0.86 in 2025 (line 92-93).

CFO flagged Q1 2026 will dip sequentially due to seasonal payroll taxes, fewer days, and start-up expenses from new facility activations, with margin normalization expected in H2 2026 (line 94). This is execution drag, not thesis invalidation.

ISAP Mix Shift — Revenue Quality Upgrade

The headline participant count (≈180,000, line 34) masks a massive revenue quality upgrade. GPS ankle monitors surged 147% from 17,000 in early 2025 to 42,000+ in February 2026 (line 35), while the cheap SmartLink phone app declined to <135,000 (line 36). Case management services now overlay 106,000 individuals (line 37).

The new 2-year ISAP contract is priced for 361,000 participants Year 1, 465,000 Year 2 (line 39). Revenue and earnings are growing even as headline participant count declines — better unit economics from higher-priced monitoring (line 38).

Skip Tracing — New Revenue Stream

GEO won a 2-year skip tracing contract worth up to $60M/year (line 41) after a successful $10M pilot in Q4 2025 (line 43). Skip tracing = enhanced location research using commercial data to find individuals on ICE's non-detained docket (line 42).

This is not detention. This is data intelligence services for ICE enforcement operations — an entirely new capability, ramping Q2+ (not yet in Q1 guidance due to protest period, line 96).

Idle Capacity Optionality

GEO has 6,000 idle beds across 6 company-owned facilities (primarily former Bureau of Prisons, high-security/cellular, line 48). Full activation = $300M+ incremental annualized revenue (line 49).

Zoley stated ICE is currently at ≈70,000 detained across 225+ locations (mostly county jails), targeting 100,000+ (line 45-46). Zoley estimates 20,000-40,000 new beds needed to reach that target (line 123).

ICE is also evaluating warehouse-to-detention conversions (coast-to-coast, complicated, politically sensitive, line 122). Zoley noted the warehouse program is "very complicated" and faces political resistance in some states, which favors established operators with existing facilities and 40-year ICE relationships (line 47).

Buyback + Balance Sheet

$500M authorization, $91M executed through YE 2025, $409M remaining (line 63-64, 105). Zoley explicitly called the stock "significantly undervalued" at a "historically low multiple" and said management will "lean into [buybacks] hard" (line 65-66, 127).

Net debt improved to ≈$1.5B with $30M annual interest expense reduction (line 99-103). Revolving credit expanded by $100M (line 100). OBBBA funds ($75B through Sept 2029) are unaffected by government shutdown risk (line 54-55).

CEO Departure — The Yellow Flag

Dave Donahue retired end of February 2026 after 11+ years at GEO (line 118-119). Founder George Zoley returned as Chairman & CEO under an amended employment agreement through April 2, 2029 (line 119-120).

This is the bearish signal. Donahue departs during peak growth cycle. Zoley — who sold approximately $2.5M in shares at $20-22 in August 2025 (75,000 shares Aug 18-20 @ avg $21.36, 41,940 shares Aug 28-29 @ avg $20.69, per Form 4 filed 08/20/2025 and Form 4 filed 09/02/2025) — is now running the company at $14.21, 30% lower.

The market reaction suggests this isn't viewed as a positive transition. Zoley's new contract runs through April 2029 with $1.2M base salary, 200% target bonus, and annual restricted stock grants worth at least 300% of salary. Per the 8-K filed February 12, Donahue will serve as a paid consultant at $104,167/month.

The Washington Litigation Context

GEO recorded a $38M non-cash contingent litigation reserve in 2025, primarily for the Nwauzor v. GEO case in Washington state (line 89). A jury found GEO liable in 2021 for violating Washington's Minimum Wage Act, awarding $17.3M in back wages to 10,000+ detainees plus $5.9M in unjust enrichment to the state.

In January 2025, the Ninth Circuit upheld the $23.2M verdict, rejecting GEO's preemption and immunity arguments. As of February 2026, the judgment stands.

$23M is not existential for a company guiding to $490-510M EBITDA in 2026. But it signals operational and legal risk that CXW doesn't face publicly. The question is whether there are other undisclosed governance or litigation issues the market is pricing in.

What's Priced In?

If the immigration enforcement thesis is correct — and both GEO and CXW confirm it is — then one of three things is true:

Analysts are wrong. The thesis is correct but GEO-specific execution, governance, or litigation risk justifies a 48% performance gap and 55% valuation discount to CXW. Market is correctly pricing in problems that aren't visible in the earnings call.
Market is wrong. GEO operational execution is real, the Washington case is a known $23M hit already reserved, and the CEO transition is benign (founder with 40-year ICE relationship leading during buildout phase). Stock is dislocated at 7% of 52-week range.
Both are partially right. GEO operational execution is strong, but governance risk (Zoley selling ≈$2.5M at higher prices, CEO transition during peak growth, undisclosed litigation exposure) creates uncertainty that will resolve only with time and execution.

Cross-Ticker Context

The immigration enforcement factor now has 8 evidence items across GEO, CXW, and GLAD (which flagged ICE activity hurting QSR credit quality in Arizona). The policy tailwind is confirmed and strengthening across multiple data sources.

CXW Q4 2025: ICE revenue +103% YoY, managing 23% of total ICE population, 11.2M shares repurchased in 2025 (10.2% of shares outstanding). CXW trades at 17.5x P/E, 2.8x net debt/EBITDA.

GEO Q4 2025: ICE population at all-time highs, $520M in new contracts, $490-510M EBITDA guidance. GEO trades at 7.8x P/E, ≈3.2x net debt/EBITDA.

The divergence is not explained by operational performance. Both are executing. Both have identical policy tailwinds through September 2029. Both are buying back stock aggressively. But GEO trades at a 48% performance discount and 55% valuation discount.

The Trade Idea

The thesis is not "GEO outright long." The thesis is "GEO/CXW spread is mispriced."

Bull case: Governance concerns are overblown. Zoley returning as CEO during peak buildout phase makes sense (founder knows ICE relationships best). Insider selling at $20-22 was routine diversification (≈$2.5M is not a full liquidation). Washington litigation is a known $23M hit already reserved. Operational execution is real and visible. GEO re-rates toward CXW's 17.5x multiple as execution continues and governance concerns fade.

Bear case: Market is correctly pricing in GEO-specific risk. Zoley sold $2.5M at much higher prices and is now CEO again during record buybacks at lower prices — optically bad. There may be other litigation, compliance, or operational issues not yet disclosed that explain the valuation gap. CXW is the cleaner vehicle for immigration enforcement exposure.

Neutral case: Both stocks benefit from immigration enforcement, but GEO carries a governance discount that may or may not resolve. Size for the factor exposure (immigration enforcement), not the single-name risk.

What's Missing

To turn this from hypothesis to recommendation, you'd need to verify:

Complete insider trading history. Zoley sold $2.5M at $20-22. Have other insiders been selling? What does the full Form 4 history show for the past year?
Detailed litigation disclosure beyond Washington case. Is there other undisclosed litigation or regulatory risk that explains the valuation gap?
Balance sheet structure comparison to CXW. Both have ≈3x net debt/EBITDA, but are there covenant or maturity differences?
State-level contract risk. GEO has significant state prison contracts (Florida, etc.). Are there political or regulatory risks at the state level that CXW doesn't face?
Why Donahue left. Retirement announcement during peak growth is unusual. What do board minutes or proxy filings say about the transition?

The worker's analysis was solid — 6 evidence items properly sourced from the transcript, all confirmed. But the more important finding is what's in the worldview: GEO and CXW have identical policy tailwinds, but GEO trades at a 48% performance discount and 55% valuation discount to CXW.

That spread is either opportunity or warning. The operational data suggests opportunity, but the governance optics (Zoley selling at $20-22, returning as CEO at $14, CEO departure during record growth) create enough uncertainty that this is a research question, not a conviction trade.

Conviction Assessment

Factor conviction (immigration enforcement): HIGH (75/100). Immigration enforcement thesis is confirmed across multiple tickers. OBBBA funding through Sept 2029 is structural. ICE populations at all-time highs across both GEO and CXW. This is real.

GEO-specific conviction: MEDIUM (55/100). Operational execution is excellent (confirmed in transcript), but governance questions (CEO transition, Zoley insider selling, litigation history) create uncertainty that can only be resolved with deeper diligence.

Edge type: If you have GEO-specific insight on governance or litigation beyond what's public, this is magnitude edge (market knows immigration enforcement thesis but is underpricing GEO operational execution). If you don't, then the trade is long CXW (cleaner vehicle for immigration enforcement factor) or GEO/CXW pair trade (bet on convergence).

Catalyst timeline: Q1 2026 earnings (April), continued ICE facility activations through H2 2026, margin normalization as start-up costs roll off, resolution of any undisclosed litigation or governance issues.

This is not "buy and forget" — this is "investigate the spread, then decide."